Home > Chemicals & Materials > Polymers > Medical Polymers > Polyglycerol Sebacate (PGS) Market

Polyglycerol Sebacate (PGS) Market Share

Report ID: GMI3101
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Polyglycerol Sebacate Market Share

Companies include, Evonik Industries AG plays a crucial role in advancing PGS through its research and development of high-performance polymers, focusing on applications in tissue engineering and regenerative medicine. Sigma-Aldrich (Merck Group) supports the PGS market by providing high-quality PGS materials for research and industrial use, facilitating advancements in drug delivery systems and tissue scaffolds. PolySciTech (Akina, Inc.) specializes in biomedical polymers, offering customized PGS solutions for various applications, including tissue engineering and medical devices.

Cambridge Polymers Group develops tailored PGS formulations for specific medical uses, such as scaffolds and coatings, enhancing material performance. BASF SE contributes through its innovation in polymer chemistry, optimizing PGS for applications in biomedical textiles and coatings.

Polyglycerol Sebacate Market Companies

Top companies operating in the polyglycerol sebacate industry include:

BASF SE
Cambridge Polymers Group
Evonik Industries AG
Fuso Chemical Co., Ltd.
Orthofix International NV
Polymers LLC
PolySciTech (Akina, Inc.)
Resinex
Secant LLC
Sigma-Aldrich (Merck Group)
Synthecon Inc.

Authors: Kiran Pulidindi, Manish Verma

Frequently Asked Questions (FAQ) :

The market size of polyglycerol sebacate reached USD 65.49 million in 2023 and is anticipated to grow at a 10.6% CAGR from 2024 to 2032.

The tissue engineering application segment held a 45% market share in 2023, amounting to USD 29.47 million, and is projected to grow at a 9% CAGR from 2024 to 2032.

The soft gel segment is projected to capture USD 43.35 million and demonstrate a 9.6% CAGR by 2032, due to their flexibility and biocompatibility, making them ideal for drug delivery systems and tissue scaffolding.

The North America market is projected to achieve USD 74.34 million, with a CAGR of 12% from 2024 to 2032, owing to a rise in the aging population and an increase in lifestyle diseases such as obesity.

Leading players in the market include BASF SE, Cambridge Polymers Group, Evonik Industries AG, Fuso Chemical Co., Ltd., Orthofix International NV, Polymers LLC, PolySciTech (Akina, Inc.), Resinex, Secant LLC, Sigma-Aldrich (Merck Group), and Synthecon Inc.